Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite

Biochemical and Biophysical Research Communications

Volumn 290, Issue 1, 2002, Pages 391-396

  Ahmed, Zakaria ^a   Ravandi, Amir ^a   Maguire, Graham F ^a   Emili, Andrew ^a,b   Draganov, Dragomir ^c   La Du, Bert N ^c   Kuksis, Arnis ^a   Connelly, Philip W ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apolipoprotein A I; Core aldehydes; Electrospray; Hydroperoxides; Isoprostanes; Lysophosphatidylcholine; Mass spectrometry; Paraoxonase 1

Indexed keywords

1 PALMITOYL 2 (5 OXO)VALEROYLGLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 (9 OXO)VALEROYLGLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 ARACHIDONOYLGLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 LINOLEOYLGLYCERO 3 PHOSPHOCHOLINE; 4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; APOLIPOPROTEIN A1; ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE; CHOLINE DERIVATIVE; ENZYME INHIBITOR; LINOLEIC ACID; LINSIDOMINE; LYSOPHOSPHATIDYLCHOLINE; PEROXYNITRITE; PHOSPHATIDYLCHOLINE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME INHIBITION; HYDROLYSIS; OXIDATION; PRIORITY JOURNAL; PROTEOLIPOSOME;

EID: 0036291526     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6150     Document Type: Article

References (45)

1. Mackness, M.I., Durrington, P.N., Mackness, B. How high-density lipoprotein protects against the effects of lipid peroxidation (2000) Current Opinion in Lipidology, 11 (4), pp. 383-388, doi: 10.1097/00041433-200008000-00007
2. Watson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Faull, K.F., Fogelman, A.M., Navab, M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein (1995) Journal of Clinical Investigation, 96 (6), pp. 2882-2891. doi: 10.1172/JCI118359
3. Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., (...), Rosenblat, M. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities (2000) Circulation, 101 (21), pp. 2510-2517. doi: 10.1161/01.CIR.101.21.2510
4. Parthasarathy, S., Barnett, J., Fong, L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein (1990) Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1044 (2), pp. 275-283. Cited 603 times.doi: 10.1016/0005-2760(90)90314-N
5. Durrington, P.N., Mackness, B., Mackness, M.I. Paraoxonase and atherosclerosis(2001) Arteriosclerosis, Thrombosis, and Vascular Biology, 21 (4), pp. 473-480. Cited 685 times. doi: 10.1161/01.ATV.21.4.473
6. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis (1998) Nature, 394 (6690), pp. 284-287. doi: 10.1038/28406
7. Mackness, Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonas(1993) Atherosclerosis, 104 (1-2), pp. 129-135.doi: 10.1016/0021-9150(93)90183-U
8. Navab, M., Hama, S.Y., Anantharamaiah, G.M., Hassan, K., Hough, G.P., Watson, A.D., Reddy, S.T., (...), Fogelman, A.M. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3.(2000) Journal of Lipid Research, 41 (9), pp. 1495-1508
9. Stremler, K.E., Stafforini, D.M., Prescott, S.M., McIntyre, T.M. Human plasma platelet-activating factor acetylhydrolase: Oxidatively fragmented phospholipids as substrates(1991) Journal of Biological Chemistry, 266 (17), pp. 11095-11103.
10. Goyal, J., Wang, K., Liu, M., Subbaiah, P.V. Novel function of lecithin-cholesterol acyltransferase: Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation (1997) Journal of Biological Chemistry, 272 (26), pp. 16231-16239. doi: 10.1074/jbc.272.26.16231
11. Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., La Du, B.N. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters(2000) Drug Metabolism and Disposition, 28 (11), pp. 1335-1342
12. La Du, B. N.1992 (Kallow, W., Ed.), pp. 51–91, Pergamon Press, New York.
13. H. Jakubowski J. Biol. Chem., 275 (2000), pp. 3957-3962
14. D.I. Draganov, P.L. Stetson, C.E. Watson, S.S. Billecke, B.N. La Du , J. Biol. Chem., 275 (2000), pp. 33435-33442
15. Z. Ahmed, A. Ravandi, G.F. Maguire, A. Emili, D. Draganov, B.N. La Du, A. Kuksis, P.W. Connelly, J. Biol. Chem., 276 (2001), pp. 24473-24481
16. C. Dentan, A.D. Tselepis, M.J. Chapman, E. Ninio, Biochim. Biophys. Acta, 1299 (1996), pp. 353-357
17. R.J. Havel, H.A. Eder, J.H. Bragdon, J. Clin. Invest., 34 (1955), pp. 1345-1353
18. M.G. Sorci-Thomas, J.S. Parks, M.W. Kearns, G.N. Pate, C. Zhang, M.J. Thomas, J. Lipid Res., 37 (1996), pp. 673-683
19. A. Ravandi, A. Kuksis, J.J. Myher, L. Marai J. Biochem. Biophys. Methods, 30 (1995), pp. 271-285
20. A.D. Watson, G. Subbanagounder, D.S. Welsbie, K.F. Faull, M. Navab, M.E. Jung, A.M. Fogelman, J.A. Berliner, J. Biol. Chem., 274 (1999), pp. 24787-24798
21. C.H. Chen, J.J. Albers, J. Lipid Res., 23 (1982), pp. 680-691
22. N.A. Shaikh, Anal. Biochem., 216 (1994), pp. 313-321
23. A. Ravandi, A. Kuksis, L. Marai, J.J. Myher, G. Steiner, G. Lewisa, H. Kamido, FEBS Lett., 381 (1996), pp. 77-81
24. W. Pruzanski, E. Stefanski, F.C. de Beer, M.C. de Beer, A. Ravandi, A. Kuksis, J. Lipid Res., 41 (2000), pp. 1035-1047
25. H.W. Eckerson, C.M. Wyte, B.N. La Du, Am. J. Hum. Genet., 35 (1983), pp. 1126-1138
26. K.N. Gan, A. Smolen, H.W. Eckerson, B.N. La Du, Drug Metab. Dispos., 19 (1991), pp. 100-106
27. C.L. Kuo, B.N. La Du, Drug Metab. Dispos., 23 (1995), pp. 935-944
28. C. Lee, F. Sigari, T. Segrado, S. Horkko, S. Hama, P.V. Subbaiah, M. Miwa, M. Navab, J.L. Witztum, P.D. Reaven, Arterioscler. Thromb. Vasc. Biol., 19 (1999), pp. 1437-1446
29. G. Subbanagounder, N. Leitinger, P.T. Shih, K.F. Faull, J.A. Berliner, Circ. Res., 85 (1999), pp. 311-318
30. A.D. Watson, M. Navab, S.Y. Hama, A. Sevanian, S.M. Prescott, D.M. Stafforini, T.M. McIntyre, B.N. Du, A.M. Fogelman, J.A. Berliner, J. Clin. Invest., 95 (1995), pp. 774-782
31. A.D. Watson, N. Leitinger, M. Navab, K.F. Faull, S. Horkko, J.L. Witztum, W. Palinski, D. Schwenke, R.G. Salomon, W. Sha, G. Subbanagounder, A.M. Fogelman, J.A. Berliner, J. Biol. Chem., 272 (1997), pp. 13597-13607
32. C. Lee, J. Barnett, P.D. Reaven, J. Lipid Res., 39 (1998), pp. 1239-1247
33. S. Ehara, M. Ueda, T. Naruko, K. Haze, A. Itoh, M. Otsuka, R. Komatsu, T. Matsuo, H. Itabe, T. Takano, Y. Tsukamoto, M. Yoshiyama, K. Takeuchi, J. Yoshikawa, A.E. Becker, Circulation, 103 (2001), pp. 1955-1960
34. Y. Nagata, Y. Yamamoto, E. Niki, Arch. Biochem. Biophys., 329 (1996), pp. 24-30
35. B. Garner, A.R. Waldeck, P.K. Witting, K.A. Rye, R. Stocker, J. Biol. Chem., 273 (1998), pp. 6088-6095
36. D.M. Stafforini, S.M. Prescott, G.A. Zimmerman, T.M. McIntyre, Biochim. Biophys. Acta, 1301 (1996), pp. 161-173
37. L. Rodrigo, B. Mackness, P.N. Durrington, A. Hernandez, M.I. Mackness, Biochem. J., 354 (2001), pp. 1-7
38. B.M. Kromer, J.R. Tippins, Br. J. Pharmacol., 119 (1996), pp. 1276-1280
39. N. Leitinger, I. Blazek, H. Sinzinger, Thromb. Res., 86 (1997), pp. 337-342
40. L.J. Roberts, J.D. Morrow, Biochim. Biophys. Acta, 1345 (1997), pp. 121-135
41. M. Aviram, M. Rosenblat, S. Billecke, J. Erogul, R. Sorenson, C.L. Bisgaier, R.S. Newton, B. La Du, Free Radical Biol. Med., 26 (1999), pp. 892-904
42. M. Aviram, M. Rosenblat, C.L. Bisgaier, R.S. Newton, S.L. Primo-Parmo, B.N. La Du, J. Clin. Invest., 101 (1998), pp. 1581-1590
43. M. Aviram, S. Billecke, R. Sorenson, C. Bisgaier, R. Newton, M. Rosenblat, J. Erogul, C. Hsu, C. Dunlop, B. La Du, Arterioscler. Thromb. Vasc. Biol., 18 (1998), pp. 1617-1624
44. H. Cao, A. Girard-Globa, F. Berthezene, P. Moulin, J. Lipid Res., 40 (1999), pp. 133-139
45. M.N. Oda, J.K. Bielicki, T. Berger, T.M. Forte, Biochemistry, 40 (2001), pp. 1710-1718